Edwards Lifesciences Corporation
EW
$75.15
-$0.74-0.98%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.90B | 3.98B | 4.45B | 1.99B | 1.70B |
| Total Receivables | 751.90M | 727.40M | 811.50M | 834.40M | 876.90M |
| Inventory | 1.11B | 1.09B | 1.10B | 1.02B | 1.21B |
| Prepaid Expenses | 111.30M | 121.00M | 114.90M | 110.20M | 138.10M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 337.10M | 374.40M | 251.00M | 556.90M | 250.60M |
| Total Current Assets | 6.21B | 6.29B | 6.73B | 4.52B | 4.17B |
|
|
|||||
| Total Current Assets | 6.21B | 6.29B | 6.73B | 4.52B | 4.17B |
| Net Property, Plant & Equipment | 1.80B | 1.78B | 1.78B | 1.73B | 1.87B |
| Long-term Investments | 1.78B | 1.78B | 1.61B | 1.15B | 1.25B |
| Goodwill | 1.78B | 1.78B | 1.61B | 1.15B | 1.25B |
| Total Other Intangibles | 1.17B | 1.18B | 956.10M | 417.10M | 446.80M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.78B | 1.72B | 1.58B | 1.93B | 1.54B |
| Total Assets | 13.02B | 13.06B | 12.97B | 10.10B | 9.74B |
|
|
|||||
| Total Accounts Payable | 172.40M | 197.40M | 172.80M | 185.90M | 212.30M |
| Total Accrued Expenses | 624.30M | 790.40M | 779.50M | 715.60M | 634.80M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 23.70M | 23.40M | 24.20M | 21.50M | 24.80M |
| Total Finance Division Other Current Liabilities | 574.40M | 494.00M | 967.60M | 294.00M | 238.90M |
| Total Other Current Liabilities | 574.40M | 494.00M | 967.60M | 294.00M | 238.90M |
| Total Current Liabilities | 1.39B | 1.51B | 1.94B | 1.22B | 1.11B |
|
|
|||||
| Total Current Liabilities | 1.39B | 1.51B | 1.94B | 1.22B | 1.11B |
| Long-Term Debt | 597.80M | 597.70M | 597.50M | 597.30M | 597.20M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 77.90M | 78.90M | 85.00M | 74.20M | 77.20M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 760.20M | 810.60M | 733.20M | 706.20M | 764.70M |
| Total Liabilities | 2.83B | 2.99B | 3.36B | 2.59B | 2.55B |
|
|
|||||
| Common Stock & APIC | 3.31B | 3.27B | 3.11B | 3.13B | 3.03B |
| Retained Earnings | 13.53B | 13.17B | 12.78B | 9.71B | 9.34B |
| Treasury Stock & Other | -6.71B | -6.44B | -6.34B | -5.40B | -5.26B |
| Total Common Equity | 10.13B | 10.00B | 9.55B | 7.44B | 7.12B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 10.13B | 10.00B | 9.55B | 7.44B | 7.12B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 62.90M | 64.50M | 65.80M | 67.20M | 68.50M |
| Total Equity | 10.19B | 10.06B | 9.61B | 7.50B | 7.19B |
|
|
|||||